These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7425161)

  • 1. Predicting outcome of antipsychotic drug treatment from early response.
    May PR; Van Putten T; Yale C
    Am J Psychiatry; 1980 Sep; 137(9):1088-9. PubMed ID: 7425161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.
    Van Putten T; May PR
    Arch Gen Psychiatry; 1978 Apr; 35(4):477-80. PubMed ID: 727898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine levels and the outcome of treatment in schizophrenic patients.
    May PR; Van Putten T; Jenden DJ; Yale C; Dixon WJ
    Arch Gen Psychiatry; 1981 Feb; 38(2):202-7. PubMed ID: 7212947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.
    Bartkó G; Herczeg I; Békésy M
    J Clin Psychiatry; 1987 Sep; 48(9):363-5. PubMed ID: 3624207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ; Doller JC
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.
    Ayers T; Liberman RP; Wallace CJ
    J Clin Psychopharmacol; 1984 Apr; 4(2):89-93. PubMed ID: 6707245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penfluridol: a long acting oral antipsychotic drug.
    Claghorn JL; Mathew RJ; Mirabi M
    J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
    Chouinard G; Pinard G; Prenoveau Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between plasma concentrations of chlorpromazine and clinical response.
    Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
    Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
    [No Abstract]   [Full Text] [Related]  

  • 10. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
    Hamill WT; Fontana AF
    Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
    Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
    Clark ML; Kaul PN
    Psychopharmacol Bull; 1975 Oct; 11(4):28-30. PubMed ID: 1105638
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroleptic hypothesis: study of the covariation of extrapyramidal and therapeutic drug effects.
    Alpert M; Diamond F; Weisenfreund J; Taleporos E; Friedhoff AJ
    Br J Psychiatry; 1978 Aug; 133():169-75. PubMed ID: 354734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased blink rate in schizophrenic patients].
    Mackert A; Woyth C; Flechtner KM; Frick K
    Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
    [No Abstract]   [Full Text] [Related]  

  • 17. [Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?].
    Strzelecki D; Rabe-Jabłońska J
    Psychiatr Pol; 2010; 44(3):395-404. PubMed ID: 20672518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and saliva levels of chlorpromazine and subjective response.
    Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
    Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.